Advertisement

Post-inflammatory Pigment Alteration

  • Rajiv I. Nijhawan
  • Andrew F. AlexisEmail author
Chapter

Abstract

Post-inflammatory pigment alteration is a common sequela of acne vulgaris in darker skin types (Fitzpatrick skin phototypes IV–VI). Acne-associated dyschromia contributes considerably to the psychological and emotional distress experienced by acne patients and can often be of greater concern to the patient than the acne itself [1–3]. Post-inflammatory hyperpigmentation is seen much more frequently than post-inflammatory hypopigmentation; however, it is important to keep in mind that in addition to acne itself, various acne treatments can cause hyper- or hypopigmentation as a result of irritation.

Keywords

Glycolic Acid Azelaic Acid Kojic Acid Grape Seed Extract Bleaching Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Davis EC, Callender VD. A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. J Clin Aesthet Dermatol. 2010;3(4):24–38. PubMed PMID: 20725545. Pubmed Central PMCID: 2921746. Epub 2010/08/21. eng.PubMedGoogle Scholar
  2. 2.
    Alexis AF. Acne in patients with skin of color. J Drugs Dermatol. 2011;10(6):s13–6. PubMed PMID: 21780341. Epub 2011/07/26. eng.PubMedGoogle Scholar
  3. 3.
    Shah SK, Alexis AF. Acne in skin of color: practical approaches to treatment. J Dermatolog Treat. 2010;21(3):206–11. PubMed PMID: 20132053. Epub 2010/02/06. eng.PubMedCrossRefGoogle Scholar
  4. 4.
    Halder RM. Hair and scalp disorders in blacks. Cutis. 1983;32(4):378–80. PubMed PMID: 6226494. Epub 1983/10/01. eng.PubMedGoogle Scholar
  5. 5.
    Alexis AF, Sergay AB, Taylor SC. Common dermatologic disorders in skin of color: a comparative practice survey. Cutis. 2007;80(5):387–94. PubMed PMID: 18189024. Epub 2008/01/15. eng.PubMedGoogle Scholar
  6. 6.
    Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002;46(2 Suppl Understanding):S98–106. PubMed PMID: 11807471. Epub 2002/01/25. eng.PubMedCrossRefGoogle Scholar
  7. 7.
    Iozumi K, Hoganson GE, Pennella R, Everett MA, Fuller BB. Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes. J Invest Dermatol. 1993;100(6):806–11. PubMed PMID: 8496620. Epub 1993/06/01. eng.PubMedCrossRefGoogle Scholar
  8. 8.
    Staricco RJ, Pinkus H. Quantitative and qualitative data on the pigment cells of adult human epidermis. J Invest Dermatol. 1957;28(1):33–45. PubMed PMID: 13416674. Epub 1957/01/01. eng.PubMedGoogle Scholar
  9. 9.
    Seiji M, Shimao K, Birbeck MS, Fitzpatrick TB. Subcellular localization of melanin biosynthesis. Ann N Y Acad Sci. 1963;100:497–533. PubMed PMID: 13992624. Epub 1963/02/15. eng.PubMedGoogle Scholar
  10. 10.
    Jimbow K, Quevedo Jr WC, Fitzpatrick TB, Szabo G. Some aspects of melanin biology: 1950–1975. J Invest Dermatol. 1976;67(1):72–89. PubMed PMID: 819593. Epub 1976/07/01. eng.PubMedCrossRefGoogle Scholar
  11. 11.
    Ruiz-Maldonado R, Orozco-Covarrubias ML. Postinflammatory hypopigmentation and hyperpigmentation. Semin Cutan Med Surg. 1997;16(1):36–43. PubMed PMID: 9125764. Epub 1997/03/01. eng.PubMedCrossRefGoogle Scholar
  12. 12.
    Grimes PE, Stockton T. Pigmentary disorders in blacks. Dermatol Clin. 1988;6(2):271–81. PubMed PMID: 3378372. Epub 1988/04/01. eng.PubMedGoogle Scholar
  13. 13.
    Grimes PE. Management of hyperpigmentation in darker racial ethnic groups. Semin Cutan Med Surg. 2009;28(2):77–85. PubMed PMID: 19608057. Epub 2009/07/18. eng.PubMedCrossRefGoogle Scholar
  14. 14.
    Halder R, Holmes Y, Bridgeman-Shah S, Kligman A. A clinical pathological study of acne vulgaris in black females. J Invest Dermatol. 1996;106(4):888.Google Scholar
  15. 15.
    Gilchrest BA, Fitzpatrick TB, Anderson RR, Parrish JA. Localization of malanin pigmentation in the skin with Wood's lamp. Br J Dermatol. 1977;96(3):245–8. PubMed PMID: 857837. Epub 1977/03/01. eng.PubMedCrossRefGoogle Scholar
  16. 16.
    Pathak MA, Riley FC, Fitzpatrick TB. Melanogenesis in human skin following exposure to long-wave ultraviolet and visible light. J Invest Dermatol. 1962;39:435–43. PubMed PMID: 13941837. Epub 1962/11/01. eng.PubMedGoogle Scholar
  17. 17.
    Summers P, Bena J, Arrigain S, Alexis AF, Cooper K, Bordeaux JS. Sunscreen use: Non-Hispanic Blacks compared with other racial and/or ethnic groups. Arch Dermatol. 2011;147(7):863–4. PubMed PMID: 21768492. Epub 2011/07/20. eng.PubMedCrossRefGoogle Scholar
  18. 18.
    Alexis AF, Lamb A. Concomitant therapy for acne in patients with skin of color: a case-based approach. Dermatol Nurs. 2009;1:33–6. PubMed PMID: 19283960. Epub 2009/03/17. eng.Google Scholar
  19. 19.
    Sheth VM, Pandya AG. Melasma: a comprehensive update Part II. J Am Acad Dermatol. 2011;65(4):699–714. PubMed PMID: 21920242. Epub 2011/09/17. eng.PubMedCrossRefGoogle Scholar
  20. 20.
    Vazquez M, Sanchez JL. The efficacy of a broad-spectrum sunscreen in the treatment of melasma. Cutis. 1983;32(1):92, 95–6. PubMed PMID: 6349944. Epub 1983/07/01. eng.Google Scholar
  21. 21.
    Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, Finkel LJ, Hamilton TA, Ellis CN, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med. 1993;328(20):1438–43. PubMed PMID: 8479462. Epub 1993/05/20. eng.PubMedCrossRefGoogle Scholar
  22. 22.
    Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis. 2006;77(1):45–50. PubMed PMID: 16475496. Epub 2006/02/16. eng.PubMedGoogle Scholar
  23. 23.
    Dogra S, Kanwar AJ, Parsad D. Adapalene in the treatment of melasma: a preliminary report. J Dermatol. 2002;29(8):539–40. PubMed PMID: 12227492. Epub 2002/09/14. eng.PubMedGoogle Scholar
  24. 24.
    Romero C, Aberdam E, Larnier C, Ortonne JP. Retinoic acid as modulator of UVB-induced melanocyte differentiation. Involvement of the melanogenic enzymes expression. J Cell Sci. 1994;107(Pt 4):1095–103. PubMed PMID: 8056833. Epub 1994/04/01. eng.PubMedGoogle Scholar
  25. 25.
    Ortonne JP. Retinoid therapy of pigmentary disorders. Dermatol Ther. 2006;19(5):280–8. PubMed PMID: 17014483. Epub 2006/10/04. eng.PubMedCrossRefGoogle Scholar
  26. 26.
    Taylor SC, Torok H, Jones T, Lowe N, Rich P, Tschen E, et al. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis. 2003;72(1):67–72. PubMed PMID: 12889718. Epub 2003/08/02. eng.PubMedGoogle Scholar
  27. 27.
    Grimes PE. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation. Cutis. 2004;74(6):362–8.PubMedGoogle Scholar
  28. 28.
    Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol. 1975;111(1):40–8. PubMed PMID: 1119822. Epub 1975/01/01. eng.PubMedCrossRefGoogle Scholar
  29. 29.
    Lynde CB, Kraft JN, Lynde CW. Topical treatments for melasma and postinflammatory hyperpigmentation. Skin Therapy Lett. 2006;11(9):1–6. PubMed PMID: 17075653. Epub 2006/11/01. eng.PubMedGoogle Scholar
  30. 30.
    Baumann L, Grimes P, Pandya AG, et al. Triple combination cream is an effective treatment for post-inflammatory hyperpigmentation. Presented at the 65th Annual American Academy of Dermatology Conference, Washington, DC, 3–5 Feb 2007Google Scholar
  31. 31.
    Guevara IL, Pandya AG. Melasma treated with hydroquinone, tretinoin, and a fluorinated steroid. Int J Dermatol. 2001;40(3):212–5. PubMed PMID: 11422530.PubMedCrossRefGoogle Scholar
  32. 32.
    Rendon M, Berneburg M, Arellano I, Picardo M. Treatment of melasma. J Am Acad Dermatol. 2006;54(5 Suppl 2):S272–81. PubMed PMID: 16631968. Epub 2006/04/25. eng.PubMedCrossRefGoogle Scholar
  33. 33.
    Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006;55(6):1048–65. PubMed PMID: 17097400. Epub 2006/11/14. eng.PubMedCrossRefGoogle Scholar
  34. 34.
    Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol. 2011;10(6):586–90. PubMed PMID: 21637899. Epub 2011/06/04. eng.PubMedGoogle Scholar
  35. 35.
    Woolery-Lloyd H, Friedman A. Optimizing patient care with “natural” products: treatment of hyperpigmentation. J Drugs Dermatol. 2009;8(6 Suppl):s10–3. PubMed PMID: 19562884. Epub 2009/07/01. eng.PubMedGoogle Scholar
  36. 36.
    Hantash BM, Jimenez F. A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma. J Drugs Dermatol. 2009;8(8):732–5. PubMed PMID: 19663110. Epub 2009/08/12. eng.PubMedGoogle Scholar
  37. 37.
    Khemis A, Kaiafa A, Queille-Roussel C, Duteil L, Ortonne JP. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. Br J Dermatol. 2007;156(5):997–1004. PubMed PMID: 17388924. Epub 2007/03/29. eng.PubMedCrossRefGoogle Scholar
  38. 38.
    Maeda K, Naganuma M. Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. J Photochem Photobiol B. 1998;47(2–3):136–41. PubMed PMID: 10093913. Epub 1999/03/27. eng.PubMedCrossRefGoogle Scholar
  39. 39.
    Briganti S, Camera E, Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res. 2003;16(2):101–10. PubMed PMID: 12622786. Epub 2003/03/08. eng.PubMedCrossRefGoogle Scholar
  40. 40.
    Paine C, Sharlow E, Liebel F, Eisinger M, Shapiro S, Seiberg M. An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway. J Invest Dermatol. 2001;116(4):587–95. PubMed PMID: 11286627. Epub 2001/04/05. eng.PubMedCrossRefGoogle Scholar
  41. 41.
    Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20–31. PubMed PMID: 12100180. Epub 2002/07/09. eng.PubMedCrossRefGoogle Scholar
  42. 42.
    Yamakoshi J, Sano A, Tokutake S, Saito M, Kikuchi M, Kubota Y, et al. Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma. Phytother Res. 2004;18(11):895–9. PubMed PMID: 15597304. Epub 2004/12/15. eng.PubMedCrossRefGoogle Scholar
  43. 43.
    Rigopoulos D, Gregoriou S, Katsambas A. Hyperpigmentation and melasma. J Cosmet Dermatol. 2007;6(3):195–202. PubMed PMID: 17760699. Epub 2007/09/01. eng.PubMedCrossRefGoogle Scholar
  44. 44.
    Sarkar R, Kaur C, Bhalla M, Kanwar AJ. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. Dermatol Surg. 2002;28(9):828–32. PubMed PMID: 12269877. discussion 32. Epub 2002/09/25. eng.PubMedCrossRefGoogle Scholar
  45. 45.
    Erbil H, Sezer E, Tastan B, Arca E, Kurumlu Z. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma. J Dermatol. 2007;34(1):25–30. PubMed PMID: 17204097. Epub 2007/01/06. eng.PubMedCrossRefGoogle Scholar
  46. 46.
    Javaheri SM, Handa S, Kaur I, Kumar B. Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Int J Dermatol. 2001;40(5):354–7. PubMed PMID: 11555002. Epub 2001/09/14. eng.PubMedCrossRefGoogle Scholar
  47. 47.
    Burns RL, Prevost-Blank PL, Lawry MA, Lawry TB, Faria DT, Fivenson DP. Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study. Dermatol Surg. 1997;23(3):171–4. PubMed PMID: 9145958. discussion 5. Epub 1997/03/01. eng.PubMedCrossRefGoogle Scholar
  48. 48.
    Lee HS, Kim IH. Salicylic acid peels for the treatment of acne vulgaris in Asian patients. Dermatol Surg. 2003;29(12):1196–9. PubMed PMID: 14725662. discussion 9. Epub 2004/01/17. eng.PubMedCrossRefGoogle Scholar
  49. 49.
    Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999;25(1):18–22. PubMed PMID: 9935087. Epub 1999/02/06. eng.PubMedCrossRefGoogle Scholar
  50. 50.
    Ahn HH, Kim IH. Whitening effect of salicylic acid peels in Asian patients. Dermatol Surg. 2006;32(3):372–5. PubMed PMID: 16640681. discussion 5. Epub 2006/04/28. eng.PubMedCrossRefGoogle Scholar
  51. 51.
    Joshi SS, Boone SL, Alam M, Yoo S, White L, Rademaker A, et al. Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin. Dermatol Surg. 2009;35(4):638–44. PubMed PMID: 19400885. discussion 44. Epub 2009/04/30. eng.PubMedCrossRefGoogle Scholar
  52. 52.
    Terrell S, Aires D, Schweiger ES. Treatment of acne vulgaris using blue light photodynamic therapy in an African-American patient. J Drugs Dermatol. 2009;8(7):669–71. PubMed PMID: 19588644. Epub 2009/07/11. eng.PubMedGoogle Scholar
  53. 53.
    Sherling M, Friedman PM, Adrian R, Burns AJ, Conn H, Fitzpatrick R, et al. Consensus recommendations on the use of an erbium-doped 1,550-nm fractionated laser and its applications in dermatologic laser surgery. Dermatol Surg. 2010;36(4):461–9. PubMed PMID: 20187898. Epub 2010/03/02. eng.PubMedCrossRefGoogle Scholar
  54. 54.
    Rahman Z, Alam M, Dover JS. Fractional Laser treatment for pigmentation and texture improvement. Skin Therapy Lett. 2006;11(9):7–11. PubMed PMID: 17075654. Epub 2006/11/01. eng.PubMedGoogle Scholar
  55. 55.
    Robins P, Battle Jr EF, Alexis AF, Cook-Bolden F, Alqubaisy Y, McLeod MP, et al. Unique laser techniques in patients with skin of color. J Drugs Dermatol. 2011;10(12):4–26. PubMed PMID: 22134557. Epub 2011/12/03. eng.Google Scholar
  56. 56.
    Callender VD. Acne in ethnic skin: special considerations for therapy. Dermatol Ther. 2004;17(2):184–95. PubMed PMID: 15113286. Epub 2004/04/29. eng.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of DermatologySt. Luke’s-Roosevelt Hospital CenterNew YorkUSA

Personalised recommendations